Marcin A. Trojanowski

Rheumatology

1 Boston Medical Ctr Pl
Boston, MA 02118

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension.

Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 11, 2026

Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.

Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.

Journal: Rheumatology (Oxford, England)

Published: August 26, 2025

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: April 24, 2025

Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways.

Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways.

Journal: Journal of scleroderma and related disorders

Published: March 13, 2025

A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis.

A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis.

Journal: PloS one

Published: February 12, 2025

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: ACR open rheumatology

Published: February 06, 2025

Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension.

Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension.

Journal: International journal of cardiology

Published: July 15, 2024

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study.

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study.

Journal: Rheumatology (Oxford, England)

Published: April 17, 2024

ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis.

ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 05, 2024

A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.

A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.

Journal: Lung

Published: July 08, 2023

Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension.

Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension.

Journal: Chest

Published: May 08, 2023

Cannabis arteritis presenting with Raynaud's and digital ulcerations: a case-based review of a controversial thromboangiitis obliterans-like condition.

Cannabis arteritis presenting with Raynaud's and digital ulcerations: a case-based review of a controversial thromboangiitis obliterans-like condition.

Journal: Clinical rheumatology

Published: February 10, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026